drugset / Trial / NCT04328740
Phase 1 Study of Oral TP-1454
NaSequentialOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of oral TP-1454 in patients with advanced metastatic or progressive solid tumors and anal cancer.
Timeline
- Start
- 2020-07-08
- Primary completion
- 2025-04-25
- Completion
- 2025-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TP-1454 | Unknown | — | Oral |